GDRX GoodRx Holdings Inc

Price (delayed)

$7.72

Market cap

$2.93B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.13

Enterprise value

$3.11B

GoodRx Holdings, Inc. is a holding company that provides price comparison tool for prescriptions. The Company provides GoodRx platform, which aggregates and analyzes pricing data from a number of different ...

Highlights
GDRX's gross profit is up by 6% year-on-year and by 2.2% since the previous quarter
The revenue is up by 4% YoY
The quick ratio has decreased by 38% YoY but it has increased by 15% from the previous quarter
GoodRx Holdings's equity has decreased by 25% YoY but it has increased by 6% from the previous quarter

Key stats

What are the main financial stats of GDRX
Market
Shares outstanding
379.45M
Market cap
$2.93B
Enterprise value
$3.11B
Valuations
Price to book (P/B)
4.33
Price to sales (P/S)
3.75
EV/EBIT
N/A
EV/EBITDA
27.55
EV/Sales
4.01
Earnings
Revenue
$775.09M
EBIT
-$547,000
EBITDA
$112.97M
Free cash flow
$64.06M
Per share
EPS
-$0.13
Free cash flow per share
$0.17
Book value per share
$1.78
Revenue per share
$2.06
TBVPS
$2.38
Balance sheet
Total assets
$1.48B
Total liabilities
$805.99M
Debt
$707.38M
Equity
$669.4M
Working capital
$648.08M
Liquidity
Debt to equity
1.06
Current ratio
7.32
Quick ratio
6.7
Net debt/EBITDA
1.62
Margins
EBITDA margin
14.6%
Gross margin
92.5%
Net margin
-7.6%
Operating margin
-3.8%
Efficiency
Return on assets
-3.8%
Return on equity
-8%
Return on invested capital
-0.1%
Return on capital employed
0%
Return on sales
-0.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GDRX stock price

How has the GoodRx Holdings stock price performed over time
Intraday
3.07%
1 week
-3.38%
1 month
13.86%
1 year
27.39%
YTD
15.22%
QTD
-1.03%

Financial performance

How have GoodRx Holdings's revenue and profit performed over time
Revenue
$775.09M
Gross profit
$716.86M
Operating income
-$29.36M
Net income
-$58.68M
Gross margin
92.5%
Net margin
-7.6%
GDRX's gross profit is up by 6% year-on-year and by 2.2% since the previous quarter
The operating margin has increased by 5% QoQ
The company's operating income rose by 5% QoQ
The revenue is up by 4% YoY

Growth

What is GoodRx Holdings's growth rate over time

Valuation

What is GoodRx Holdings stock price valuation
P/E
N/A
P/B
4.33
P/S
3.75
EV/EBIT
N/A
EV/EBITDA
27.55
EV/Sales
4.01
GDRX's P/B is 58% below its 5-year quarterly average of 10.0 but 14% above its last 4 quarters average of 3.7
GoodRx Holdings's equity has decreased by 25% YoY but it has increased by 6% from the previous quarter
The price to sales (P/S) is 68% lower than the 5-year quarterly average of 11.2
The revenue is up by 4% YoY

Efficiency

How efficient is GoodRx Holdings business performance
The company's return on invested capital has shrunk by 102% YoY
The company's return on sales has shrunk by 102% YoY

Dividends

What is GDRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GDRX.

Financial health

How did GoodRx Holdings financials performed over time
GoodRx Holdings's total assets is 83% more than its total liabilities
The quick ratio has decreased by 38% YoY but it has increased by 15% from the previous quarter
The company's current ratio fell by 34% YoY but it rose by 16% QoQ
The debt is 6% more than the equity
GDRX's debt to equity is up by 33% year-on-year but it is down by 6% since the previous quarter
GoodRx Holdings's equity has decreased by 25% YoY but it has increased by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.